CR overview
CR: BRD3
Accession: Q15059
Protein names: Bromodomain-containing protein 3 short isoform
Function type: Histone Modifier
Histone type: Reader
Methytor type: Unkown
Aliases: Bromo-PHD
PMID: 32895492 21536911 34482332
Disease: 8
Go term: 5
Pathway: --
Hallmark: --
Super Enhancer:

chr9:136904463-136934225 chr9:136913824-136934451 chr9:136909120-136944082 chr9:136917526-136934650 chr9:136918029-136934417 chr9:136904848-136932503 chr9:136913423-136922260 chr9:136889544-136944540 chr9:136893678-136934356 chr9:136893397-136934497 chr9:136893775-136935570

Enhancer:

chr9:136814680-136817100 chr9:136890660-136890960 chr9:136891210-136891320 chr9:136335910-136336210 chr9:136341460-136342150 chr9:136400040-136401680 chr9:136644010-136645030 chr9:136645060-136645810 chr9:136649540-136650890 chr9:136912040-136912550 chr9:136912590-136912860 chr9:136601840-136603370 chr9:136678620-136680830 chr9:136724760-136726490 chr9:136729820-136730020 chr9:136750370-136750970 chr9:136924300-136926040 chr9:136926190-136928560 chr9:136929880-136930390 chr9:137027180-137029560 chr9:136854720-136857190 chr9:136913580-136915490 chr9:136915710-136916680 chr9:136905400-136906880 chr9:136790350-136792840 chr9:136812170-136814340 chr9:136823880-136824630 chr9:136825450-136826420 chr9:136833010-136834750 chr9:136272200-136272930 chr9:137021720-137023010 chr9:137326050-137328310 chr9:136527530-136528680 chr9:137005930-137006630 chr9:136704260-136706470 chr9:136762110-136764150 chr9:136566080-136568030 chr9:136771360-136771580 chr9:136771750-136773420 chr9:136776650-136777000 chr9:136782130-136783940 chr9:136707020-136707550 chr9:136738200-136740700 chr9:137243480-137245850 chr9:137245870-137247340 chr9:137250120-137251040 chr9:137251240-137251920 chr9:137261150-137262690 chr9:137265650-137266140 chr9:137299340-137299990 chr9:137300150-137300780 chr9:137300970-137303290 chr9:137304910-137307040 chr9:137248360-137249500 chr9:136342360-136343370 chr9:136409670-136412150 chr9:136439110-136439860 chr9:136568150-136570060 chr9:136641710-136642510 chr9:136642590-136643880 chr9:136648710-136649430 chr9:136653610-136654370 chr9:136654470-136656900 chr9:135960430-135961640 chr9:136834990-136836080 chr9:136613500-136615990 chr9:136619700-136620280 chr9:136683520-136684370 chr9:136719590-136719800 chr9:137323840-137325940 chr9:137338030-137340300 chr9:137340650-137343100 chr9:137368220-137368700 chr9:137393590-137395970 chr9:136740930-136742680 chr9:137481970-137482830 chr9:137483190-137484970 chr9:137514660-137515870 chr9:137516510-137517420 chr9:137518330-137518850 chr9:137534140-137536140 chr9:137396180-137396870 chr9:137493410-137495270 chr9:136547920-136550240 chr9:136599330-136601550 chr9:137307390-137309000 chr9:137276430-137278900 chr9:137279990-137281260 chr9:136638790-136640050 chr9:136734310-136735970 chr9:136871950-136873020 chr9:136917680-136918380 chr9:137016110-137016520

Promoter:

chr9:134066535-134070535

 ChIP-seq based regulatory details of BRD3
Sample ID CR Biosample type Biosample term name File accession Experiment accession Source
CR_02_0014 BRD3 cell line MM1.S SRR1015260 GSE43743 GEO
CR_02_0194 BRD3 cell line HCT116 SRR11969128 GSE152144 GEO
CR_02_0195 BRD3 cell line HCT116 SRR11969129 GSE152144 GEO
CR_02_0303 BRD3 cell line LX-2 SRR1427129 GSE58680 GEO
CR_02_0356 BRD3 cell line H9 SRR1537742 GSE60171 GEO
CR_02_0357 BRD3 cell line H9 SRR1537743 GSE60171 GEO
CR_02_0503 BRD3 cell line MutuI SRR3822410 GSE84214 GEO
CR_02_0504 BRD3 cell line MutuI SRR3822411 GSE84213 GEO
CR_02_0768 BRD3 cell line MCF-7 SRR6507229 GSE109572/GSE109571 GEO
CR_02_0769 BRD3 cell line MCF-7 SRR6507230 GSE109572/GSE109571 GEO
CR_02_0770 BRD3 cell line MCF-7 SRR6507231 GSE109572/GSE109571 GEO
CR_02_0771 BRD3 cell line MCF-7 SRR6507232 GSE109572/GSE109571 GEO
CR_02_0783 BRD3 cell line liposarcoma cells SRR6792591 GSE111254/GSE111253 GEO
CR_02_0913 BRD3 cell line A549 SRR7822628 GSE119863 GEO
CR_02_0942 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947485 GSE120715 GEO
CR_02_0943 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947486 GSE120715 GEO
CR_02_0944 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947487 GSE120715 GEO
CR_02_0945 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947488 GSE120715 GEO
CR_02_0946 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947489 GSE120715 GEO
CR_02_0947 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947490 GSE120715 GEO
CR_02_0948 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947491 GSE120715 GEO
CR_02_0949 BRD3 Tissue Chronic Myelogenous Leukemia SRR7947492 GSE120715 GEO
CR_02_0950 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947493 GSE120715 GEO
CR_02_0951 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947494 GSE120715 GEO
CR_02_0952 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947495 GSE120715 GEO
CR_02_0953 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947496 GSE120715 GEO
CR_02_0954 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947497 GSE120715 GEO
CR_02_0955 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947498 GSE120715 GEO
CR_02_0956 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947499 GSE120715 GEO
CR_02_0957 BRD3 Tissue Biphenotypic B Myelomonocytic Leukemia SRR7947500 GSE120715 GEO
CR_02_1447 BRD3 cell line MM1.S SRR1015258 GSE43743 GEO
CR_02_1448 BRD3 cell line MM1.S SRR1015259 GSE43743 GEO
CR_02_1502 BRD3 cell line LX-2 SRR1427128 GSE58680 GEO
 Downstream target genes of BRD3
 Protein-protein interaction of BRD3
 Annotation of BRD3
 TCGA cancer survival map of BRD3


Calculate the hazards ratio based on Cox PH Model.
Add the 95% CI as dotted line.
Reset Add The plot axis-x order will follow the list.


Calculate the hazards ratio based on Cox PH Model.
We use log2(TPM + 1) for log-scale.
All Add
Reset The plot is based on the datasets of list.